Literature DB >> 4333047

Growth inhibition of sympathetic cells by some adrenergic blocking agents (6-hydroxydopamine-mice and rats-immunosympathectomy-chemical sympathectomy-superior cervical ganglion).

P U Angeletti, R Levi-Montalcini.   

Abstract

Treatment of newborn mice and rats with the adrenergic blocking agents, guanethidine and bretylium tosylate, results in massive destruction of immature sympathetic nerve cells. A growth inhibition of the same cells is caused by reserpine. Similarities and differences between the effects elicited by these three ganglion blocking agents and a dopamine analog, 6-hydroxydopamine, are discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4333047      PMCID: PMC427550          DOI: 10.1073/pnas.69.1.86

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  6 in total

1.  INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS.

Authors:  C C CHANG; E COSTA; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1965-03       Impact factor: 4.030

2.  The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves.

Authors:  A L BOURA; F C COPP; W G DUNCOMBE; A F GREEN; A McCOUBREY
Journal:  Br J Pharmacol Chemother       Date:  1960-06

3.  DESTRUCTION OF THE SYMPATHETIC GANGLIA IN MAMMALS BY AN ANTISERUM TO A NERVE-GROWTH PROTEIN.

Authors:  R Levi-Montalcini; B Booker
Journal:  Proc Natl Acad Sci U S A       Date:  1960-03       Impact factor: 11.205

4.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

5.  Sympathetic nerve cell destruction in newborn mammals by 6-hydroxydopamine.

Authors:  P U Angeletti; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1970-01       Impact factor: 11.205

6.  Second symposium on catecholamines. Modification of sympathetic function. Immunosympathectomy.

Authors:  R Levi-Montalcini; P U Angeletti
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

  6 in total
  7 in total

1.  Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome.

Authors:  D S Goldstein; A McRae; C Holmes; M C Dalakas
Journal:  Clin Auton Res       Date:  1996-02       Impact factor: 4.435

Review 2.  The value of the fluorescence histochemistry of biogenic amines in neurotoxicology.

Authors:  G Krinke; R Hess
Journal:  Histochem J       Date:  1981-09

3.  Growth of sympathetic postganglionic axons after partial chemical destruction with guanethidine.

Authors:  I M Rodionov; V N Yarygin; A Mukhammedov; B N Manukhin; D B Lebedev; L A Nesterova
Journal:  Pflugers Arch       Date:  1981-12       Impact factor: 3.657

4.  Ganglion cells and paraganglionic cells in the developing superior cervical ganglion of normal and p-chlorophenylalanine treated rats.

Authors:  C Heym
Journal:  Cell Tissue Res       Date:  1975-11-07       Impact factor: 5.249

5.  Absence of sensory neurons before target innervation in brain-derived neurotrophic factor-, neurotrophin 3-, and TrkC-deficient embryonic mice.

Authors:  D J Liebl; L Tessarollo; M E Palko; L F Parada
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

6.  Age-Related Dopaminergic Innervation Augments T Helper 2-Type Allergic Inflammation in the Postnatal Lung.

Authors:  Wei Wang; Jonathan A Cohen; Antonia Wallrapp; Kenneth G Trieu; Juliana Barrios; Fengzhi Shao; Nandini Krishnamoorthy; Vijay K Kuchroo; Matthew R Jones; Alan Fine; Yan Bai; Xingbin Ai
Journal:  Immunity       Date:  2019-11-19       Impact factor: 31.745

7.  Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways.

Authors:  D Engler; D Chad; I M Jackson
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.